| 查看: 281 | 回复: 1 | ||
[求助]
求高人翻译下下
|
|
1. JoA score is a general myelopathy functional measurement. It appears that a large segment of the patient population treated had moderate to severe levels of myelopathy, given their preop score of 10. Please clarify if this score was prospectively obtained at each patient visit, or was it retrospectively reconstructed by the examiners? Given the severity of the myelopathy described, why was no ASIA motor score obtained? Why no health related quality of life score? 2. The authors state that fusion assessed commonly accepted parameters, yet they didn't provide any data on flexion extension radiographs and their interspinous motion, presence of sentinel sign, radiolucency around endplates on lateral imaging and supplemental CT in case of doubtful fusion? 3. In terms of making any claims about fusion by looking at lateral radiographs at a 12 month follow-up I would ask for rephrasing of the title and all pertinent arts of the article to reflect 'early' follow-up. These implants don't really allow assessment of bony in-growth due to their material composition and therefore require ore stringent and longer follow-up to declare 'fusion'. |
回复此楼» 猜你喜欢
化学357分，考研调剂
已经有6人回复
-
288环境专硕,求调材料方向
已经有7人回复
-
315求调剂
已经有6人回复
-
325求调剂
已经有3人回复
-
一志愿电子科技大学085600材料与化工 329分求调剂
已经有3人回复
-
0855求调剂材料
已经有3人回复
-
358求调剂
已经有5人回复
-
333求调剂
已经有13人回复
-
085600调剂
已经有7人回复
-
0703化学
已经有9人回复
2楼2012-10-12 17:04:58
